Results 11 to 20 of about 26,063 (258)

Combined oral contraceptives effects on body mass [PDF]

, 2022
The aim of the study - determine the effect of combined oral contraceptives on women’s body weightЦель исследования - установить влияние комбинированных оральных контрацептивов на массу тела ...
Krasilnikova, N. E., Koval, M. V., Коваль, М. В., Красильникова, Н. Е.   +3 more
core  

Ziprasidone and the pharmacokinetics of a combined oral contraceptive [PDF]

British Journal of Clinical Pharmacology, 2000
Aims  To determine whether multiple doses of ziprasidone alter the steady‐state pharmacokinetics of the component steroids, ethinyloestradiol and levonorgestrel, of an oral contraceptive; to evaluate the tolerability of a co‐administered combined oral contraceptive and ziprasidone; and to compare plasma concentrations of prolactin in subjects taking a ...
G J, Muirhead, J, Harness, P R, Holt, S, Oliver, R J, Anziano   +4 more
openaire   +2 more sources

Guidelines for prescribing combined oral contraceptives [PDF]

BMJ, 1996
EDITOR,—The clinical and scientific committee of the Faculty of Family Planning and Reproductive Health Care has noted a wide range of expert views on the recent publications on the combined oral contraceptive and venous thromboembolism1 2 3 4 5 6 and has circulated a position paper.7 The new studies confirm that low dose combined oral contraceptives ...
A M, Mills, C L, Wilkinson, D R, Bromham, J, Elias, K, Fotherby, J, Guillebaud, A, Kubba, A, Wade   +7 more
openaire   +2 more sources

The impact of oral contraceptive initiation on young women's condom use in 3 American Cities: Missed opportunities for intervention

, 2014
Purpose: To describe women's condom use and assess predictors of consistent condom use and dual method use in the 6 months after the initiation of oral contraception (OC). Methods: We conducted a planned secondary cohort analysis among women less than 25
Sharon Edwards, Heartwell, S, Heartwell, Stephen, Stephen Heartwell, Carolyn Westhoff, Morroni, Chelsea, Edwards, S, Zieman, Mimi, Westhoff, C, Morroni, C, Chelsea Morroni, Westhoff, Carolyn Louise, Mimi Zieman, Edwards, Sharon, Zieman, M   +14 more
core   +1 more source

Examining the use of oral contraceptives in the management of acne

, 2010
Heather L Salvaggio1, Andrea L Zaenglein1,21Departments of Dermatology and 2Pediatrics, Penn State/Milton S. Hershey Medical Center, Hershey, PA, USAAbstract: Combined oral contraceptive pills (cOCPs) are often used in the treatment of acne in females ...
Zaenglein, Andrea L, Andrea L Zaenglein, Heather L Salvaggio, Salvaggio, Heather L, null Heather L Salvaggio, Andrea Zaenglein   +5 more
core   +1 more source

Acne resolution rates: Results of a single-blind, randomized, controlled, parallel phase III trial with EE/CMA (Belara (R)) and EE/LNG (Microgynon (R)) [PDF]

, 2001
Background and Objective: Acne in women can often be successfully treated by the intake of oral contraceptives containing gestagens with anti-androgenic properties.
Zahradnik, H. P., Arp, W., Andreas, J. O., Binder, N., Worret, I.   +4 more
core   +1 more source

The Role of Hematopoietic Cell Transplantation in Ataxia‐Telangiectasia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Ataxia‐telangiectasia (A‐T) is a DNA repair disorder characterized by neurodegeneration, immunodeficiency, and cancer predisposition. Hematopoietic cell transplantation (HCT) is an established therapy in related disorders such as Fanconi anemia (FA) and Nijmegen breakage syndrome (NBS), but its role in A‐T is unclear.
Laila Alkhouli, Seth Rotz, Masatoshi Takagi, Richa Sharma   +3 more
wiley   +1 more source

A Systematic Review and Meta‐Analysis of the Recurrence of Autoimmune Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune encephalitis (AE) is a disease with a potential for recurrence, and patients receive immunotherapy to prevent it. However, there is no consensus on the duration of immunotherapy. This study aimed to determine the recurrence rate and identify the risk factors for AE to provide guidance on the duration of immunotherapy ...
Shangkai Bai, Sen Zhang, Haipei Zhang, Yating Zhang, Junhong Guo, Xiaoyan Yang   +5 more
wiley   +1 more source

Assessing the Sensitivity and the Clinical Impact of the 2023 American College of Rheumatology/EULAR Classification Criteria in Obstetric Antiphospholid Syndrome: Findings From a Multicenter Italian Cohort With a Long‐Term Follow‐Up

Arthritis Care &Research, EarlyView.
Objective The aim of this study was to evaluate the sensitivity of the 2023 American College of Rheumatology (ACR)/EULAR classification criteria for antiphospholipid syndrome (APS) in a real‐world cohort of women diagnosed with primary obstetric APS (oAPS) and to assess their ability to identify patients at risk of future pregnancy complications ...
Francesca Ruffilli, Cecilia Nalli, Francesca Crisafulli, Carlo Garaffoni, Marcello Govoni, Giulia Voltarel, Alba C. Pozzi, Beatrice Maranini, Ettore Silvagni, Alessandra Bortoluzzi, Angela Tincani   +10 more
wiley   +1 more source

Building a Framework for Sexual and Reproductive Health Care in the Rheumatology Context: Content and Approaches

Arthritis Care &Research, EarlyView.
People with systemic autoimmune and rheumatic diseases (SARDs) are at higher risk than the general population of experiencing adverse pregnancy and perinatal outcomes such as preeclampsia, intrauterine growth restriction, and maternal and/or fetal death.
Mehret Birru Talabi, Sonya Borrero
wiley   +1 more source